… of COVID-19 is … COVID-19 has also seen some twists and controversies, such as potential
drugs and the role of vaccines. In view of the fact that research on SARS-CoV-2 and COVID-19 …

… coronavirus disease 2019 (COVID-19), produced by the severe acute respiratory syndrome
coronavirus 2 (… The absence of effective therapies when disease progresses to a very severe …

… This review also discusses the latest recommendations for anticoagulant therapy in
patients with severe COVID-19 as well as its potential effects and harms stroke outcome. …

… COVID-19 is already underway, and new information is being provided every day, some of
which are contradictory. COVID-19 … Conclusion Since the exact mechanism of the COVID-19 …

… Therefore, identifying the distinctive features of this severe and fatal disease and the
therapeutic approaches to COVID-19-induced ARDS remains an immediate need to serve as a …

… Figure 1 presents the general scheme of the COVID-19 immunopathogenesis. … , was used
as a part of a combination therapy to treat 6 COVID-19 patients with acute respiratory distress …

… a therapeutic target in COVID-19. An in-depth discussion of the underlying mechanisms of
COVID-19 pathogenesis will be conducive to the identification of potential therapeutic targets …

… COVID-19 patients, including convalescent plasma therapy (… (31 patients), mesenchymal
stem cell therapy (8 patient), and … for the variable immunopathogenesis of COVID-19 infections …

… , are considered the main reasons for immunopathogenesis and inflammation in SARS-CoV-…
Consequent to different findings of the study in terms of CP therapy effect against COVID-19…

… therapeutic dichotomy to better understand the immunopathology of moderate-to-severe
COVID-19, … We focus on patients with moderate-to-severe COVID-19, rather than on those with …